Now Undervalued, Should You Invest in Allergan (AGN)?

Mere weeks after its failed merger with Pfizer (PFE), global pharmaceutical company Allergan PLC (AGN), maker of Viagra and Botox, announced a new $10 billion share repurchase authorization. Allergan plans to complete the $40 billion sale of its generic pharmaceutical business to Pharmaceuticals...
Read More